These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 26386926)
1. Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance. Caminiti G; Fossati C; Rosano G; Volterrani M Int J Cardiol; 2016 Jan; 202():73-4. PubMed ID: 26386926 [No Abstract] [Full Text] [Related]
2. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life. Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314 [TBL] [Abstract][Full Text] [Related]
3. Emerging role of ivabradine for rate control in atrial fibrillation. Turley SL; Francis KE; Lowe DK; Cahoon WD Ther Adv Cardiovasc Dis; 2016 Dec; 10(6):348-352. PubMed ID: 27659287 [TBL] [Abstract][Full Text] [Related]
4. Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation. Verrier RL; Silva AF; Bonatti R; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L J Cardiovasc Electrophysiol; 2015 Mar; 26(3):329-35. PubMed ID: 25346368 [TBL] [Abstract][Full Text] [Related]
5. Ivabradine for rate control in atrial fibrillation. Kosiuk J; Oebel S; John S; Hilbert S; Hindricks G; Bollmann A Int J Cardiol; 2015 Jan; 179():27-8. PubMed ID: 25464400 [No Abstract] [Full Text] [Related]
6. [Efficacy of ivabradine in patients with stable angina and comorbid chronic obstructive pulmonary disease]. Khamaeva AA; Belialov FI; Kerzina LV; Berezovskaia OV; Parshukova ED; Zakharova GIu Kardiologiia; 2012; 52(1):15-9. PubMed ID: 22304347 [TBL] [Abstract][Full Text] [Related]
7. Funny and late: targeting currents governing heart rate in atrial fibrillation. Daniels JD; Hill JA J Cardiovasc Electrophysiol; 2015 Mar; 26(3):336-8. PubMed ID: 25511517 [No Abstract] [Full Text] [Related]
8. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina. Amosova E; Andrejev E; Zaderey I; Rudenko U; Ceconi C; Ferrari R Cardiovasc Drugs Ther; 2011 Dec; 25(6):531-7. PubMed ID: 21830063 [TBL] [Abstract][Full Text] [Related]
9. [Effect of ivabradine on pulmonary hypertension in chronic obstructive pulmonary disease]. Akhmetzianova ÉKh; Gaĭnitdinova VV; Bakirov AB; Bogoroditskaia OA; Timershina IR Kardiologiia; 2012; 52(2):41-6. PubMed ID: 22792738 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of ivabradine and atenolol in patients with moderate mitral stenosis in sinus rhythm. Rajesh GN; Sajeer K; Sajeev CG; Bastian C; Vinayakumar D; Muneer K; Haridasan V; Mathew D; George B; Krishnan MN Indian Heart J; 2016; 68(3):311-5. PubMed ID: 27316483 [TBL] [Abstract][Full Text] [Related]
11. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation. Wongcharoen W; Ruttanaphol A; Gunaparn S; Phrommintikul A Int J Cardiol; 2016 Dec; 224():252-255. PubMed ID: 27661415 [TBL] [Abstract][Full Text] [Related]
13. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report. Núñez L; Crespo-Leiro MG; Marrón-Liñares GM; Suarez-Fuentetaja N; Barge-Caballero E; Paniagua-Martín MJ; Marzoa-Rivas R; Grille-Cancela Z; Muñiz-García J; Vazquez-Rodriguez JM; Hermida-Prieto M Cardiol J; 2016; 23(5):573-582. PubMed ID: 27439367 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation. Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296 [TBL] [Abstract][Full Text] [Related]
15. Ivabradine and AV conduction. Tomcsányi J; Toldy-Schedel E; Somlói M Int J Cardiol; 2015 Feb; 181():53-4. PubMed ID: 25482278 [No Abstract] [Full Text] [Related]
16. Effect of selective heart rate reduction through sinus node I Sisakian H; Sargsyan T; Khachatryan A Acta Cardiol; 2016 Jun; 71(3):317-22. PubMed ID: 27594127 [No Abstract] [Full Text] [Related]
17. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine. Doesch AO; Celik S; Ehlermann P; Frankenstein L; Zehelein J; Koch A; Katus HA; Dengler TJ Transplantation; 2007 Oct; 84(8):988-96. PubMed ID: 17989604 [TBL] [Abstract][Full Text] [Related]
18. Need for further studies on ivabradine in patients with persistent atrial fibrillation. Kosiuk J; Lindemann F; Hindricks G; Bollmann A Int J Cardiol; 2016 Nov; 223():915-916. PubMed ID: 27589039 [No Abstract] [Full Text] [Related]
19. Metoprolol vs ivabradine in patients with mitral stenosis in sinus rhythm. Agrawal V; Kumar N; Lohiya B; Sihag BK; Prajapati R; Singh TB; Subramanian G Int J Cardiol; 2016 Oct; 221():562-6. PubMed ID: 27420578 [TBL] [Abstract][Full Text] [Related]
20. [Effect of the I(f) channel blocker ivabradine on the parameters of external respiration function in patients with chronic obstructive pulmonary disease in its stable course period]. Komlev AD; Kuziaev AI; Laskin GM; Kuzenkova VE; Kolosova MV Ter Arkh; 2010; 82(3):23-5. PubMed ID: 20564916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]